Helicos BioSciences , Nasdaq: HLCS
Developing genetic analysis technologies for research and drug discovery uses.
Industry: Health Care
First Day Return: -5.9%
Industry: Health Care
HLCS
Developing genetic analysis technologies for research and drug discovery uses.
| IPO Data | |
|---|---|
| IPO File Date | 02/28/2007 |
| Offer Price | $9.00 |
| Price Range $13.00 - $15.00 | |
| Offer Shares (mm) | 5.4 |
| Deal Size ($mm) | $49 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 05/23/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $49 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Cambridge, MA, United States |
| Founded | 2003 |
| Employees at IPO | n/a |
| Website www.helicosbio.com | |
IPO News for Helicos BioSciences
Helicos BioSciences (HLCS) Performance
